Pro Detailing Shares Hit by Court Decision

Semtech sees third-quarter sales growth; Polymedica gets hit with grand jury subpoena; plus more of today's stocks in the news

Merrill downgraded Professional Detailing (PDII ). On Monday, a court vacated a preliminary injunction against Ranbaxy Pharmaceutical; Ranbaxy could market a generic version of Ceftin, an antibiotic Pro Detailing markets for GlaxoSmithKline. That company's action against Ranbaxy remains pending.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.